These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30132674)

  • 1. Nanoengineering of Poly(ethylene glycol) Particles for Stealth and Targeting.
    Cui J; Björnmalm M; Ju Y; Caruso F
    Langmuir; 2018 Sep; 34(37):10817-10827. PubMed ID: 30132674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering poly(ethylene glycol) particles for targeted drug delivery.
    Li S; Ma Y; Cui J; Caruso F; Ju Y
    Chem Commun (Camb); 2024 Feb; 60(19):2591-2604. PubMed ID: 38285062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-controlled release of Oxaliplatin prodrug from d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) functionalized mesoporous silica nanoparticles for cancer therapy.
    Liang C; Wang H; Zhang M; Cheng W; Li Z; Nie J; Liu G; Lian D; Xie Z; Huang L; Zeng X
    J Colloid Interface Sci; 2018 Sep; 525():1-10. PubMed ID: 29679795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Block co-polymer nanoparticles with degradable cross-linked core and low-molecular-weight PEG corona for anti-tumour drug delivery.
    Abraham G; McCarroll J; Byrne F; Saricilar S; Kavallaris M; Bulmus V
    J Biomater Sci Polym Ed; 2011; 22(8):1001-22. PubMed ID: 20566070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Poly(ethylene glycol) Molecular Architecture on Particle Assembly and
    Song J; Ju Y; Amarasena TH; Lin Z; Mettu S; Zhou J; Rahim MA; Ang CS; Cortez-Jugo C; Kent SJ; Caruso F
    ACS Nano; 2021 Jun; 15(6):10025-10038. PubMed ID: 34009935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering poly(ethylene glycol) particles for improved biodistribution.
    Cui J; De Rose R; Alt K; Alcantara S; Paterson BM; Liang K; Hu M; Richardson JJ; Yan Y; Jeffery CM; Price RI; Peter K; Hagemeyer CE; Donnelly PS; Kent SJ; Caruso F
    ACS Nano; 2015 Feb; 9(2):1571-80. PubMed ID: 25712853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulating the surface poly(ethylene glycol) density of polymeric nanoparticles and evaluating its role in drug delivery in vivo.
    Du XJ; Wang JL; Liu WW; Yang JX; Sun CY; Sun R; Li HJ; Shen S; Luo YL; Ye XD; Zhu YH; Yang XZ; Wang J
    Biomaterials; 2015 Nov; 69():1-11. PubMed ID: 26275857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific Antibodies.
    Cui J; Ju Y; Houston ZH; Glass JJ; Fletcher NL; Alcantara S; Dai Q; Howard CB; Mahler SM; Wheatley AK; De Rose R; Brannon PT; Paterson BM; Donnelly PS; Thurecht KJ; Caruso F; Kent SJ
    Adv Healthc Mater; 2019 May; 8(9):e1801607. PubMed ID: 30868751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clustered nanobody-drug conjugates for targeted cancer therapy.
    Wu T; Liu M; Huang H; Sheng Y; Xiao H; Liu Y
    Chem Commun (Camb); 2020 Aug; 56(65):9344-9347. PubMed ID: 32672289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of amphiphilic block polymer poly(ethylene glycol)-poly(propylene carbonate)-poly(ethylene glycol) for drug delivery.
    Li H; Niu Y
    Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():160-165. PubMed ID: 29752085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary study on MeO-PEG-PLGA-PEG-OMe nanoparticles as intravenous carriers.
    Duan Y; Xu J; Lin Y; Yu H; Gong T; Li Y; Zhang Z
    J Biomed Mater Res A; 2008 Nov; 87(2):515-23. PubMed ID: 18186066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-Functionalized Poly(ethylene glycol) Particles for Tumor Targeting and Intracellular Uptake.
    Cui J; Alt K; Ju Y; Gunawan ST; Braunger JA; Wang TY; Dai Y; Dai Q; Richardson JJ; Guo J; Björnmalm M; Hagemeyer CE; Caruso F
    Biomacromolecules; 2019 Sep; 20(9):3592-3600. PubMed ID: 31448896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed micelles of lipoic acid-chitosan-poly(ethylene glycol) and distearoylphosphatidylethanolamine-poly(ethylene glycol) for tumor delivery.
    Elsaid Z; Taylor KM; Puri S; Eberlein CA; Al-Jamal K; Bai J; Klippstein R; Wang JT; Forbes B; Chana J; Somavarapu S
    Eur J Pharm Sci; 2017 Apr; 101():228-242. PubMed ID: 28163163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
    Xu M; Qian J; Liu X; Liu T; Wang H
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Templated Polymer Replica Nanoparticles to Facilitate Assessment of Material-Dependent Pharmacokinetics and Biodistribution.
    Song D; Cui J; Sun H; Nguyen TH; Alcantara S; De Rose R; Kent SJ; Porter CJH; Caruso F
    ACS Appl Mater Interfaces; 2017 Oct; 9(39):33683-33694. PubMed ID: 28945344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
    Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
    J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.
    Deng L; Dong H; Dong A; Zhang J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering Well-Characterized PEG-Coated Nanoparticles for Elucidating Biological Barriers to Drug Delivery.
    Yang Q; Lai SK
    Methods Mol Biol; 2017; 1530():125-137. PubMed ID: 28150200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.